View in EDS PDF Full Text

Computational discovery of lead compounds targeting G1202R-based ALK triple mutations conferring lorlatinib resistance in EML4-ALK variant 3 non-small cell lung cancer.

Saved in:
Bibliographic Details
Title: Computational discovery of lead compounds targeting G1202R-based ALK triple mutations conferring lorlatinib resistance in EML4-ALK variant 3 non-small cell lung cancer.
Authors: Bharath, Palani1, Vignesh, Sivaprakasam1, D., Thirumal Kumar1 thirumal@maher.ac.in
Source: Journal of Applied Pharmaceutical Science. Apr2026, Vol. 16 Issue 4, p304-321. 18p.
Database: Academic Search Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 192718320
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Computational discovery of lead compounds targeting G1202R-based ALK triple mutations conferring lorlatinib resistance in EML4-ALK variant 3 non-small cell lung cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Bharath%2C+Palani%22">Bharath, Palani</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Vignesh%2C+Sivaprakasam%22">Vignesh, Sivaprakasam</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22D%2E%2C+Thirumal+Kumar%22">D., Thirumal Kumar</searchLink><relatesTo>1</relatesTo><i> thirumal@maher.ac.in</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Journal+of+Applied+Pharmaceutical+Science%22">Journal of Applied Pharmaceutical Science</searchLink>. Apr2026, Vol. 16 Issue 4, p304-321. 18p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=192718320
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.7324/JAPS.2026.264285
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 18
        StartPage: 304
    Titles:
      – TitleFull: Computational discovery of lead compounds targeting G1202R-based ALK triple mutations conferring lorlatinib resistance in EML4-ALK variant 3 non-small cell lung cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bharath, Palani
      – PersonEntity:
          Name:
            NameFull: Vignesh, Sivaprakasam
      – PersonEntity:
          Name:
            NameFull: D., Thirumal Kumar
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: Apr2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 22313354
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Journal of Applied Pharmaceutical Science
              Type: main
ResultId 1